![InfoCancer - ARCAGY - GINECO - Localisations - Cancers masculins - Cancer de la prostate - Symptômes & diagnostic - Le bilan initial InfoCancer - ARCAGY - GINECO - Localisations - Cancers masculins - Cancer de la prostate - Symptômes & diagnostic - Le bilan initial](https://www.arcagy.org/infocancer/img/497_popup_toucher-rectal-0565209.jpg)
InfoCancer - ARCAGY - GINECO - Localisations - Cancers masculins - Cancer de la prostate - Symptômes & diagnostic - Le bilan initial
![Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm | British Journal of General Practice Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm | British Journal of General Practice](https://bjgp.org/content/bjgp/71/706/e364/F1.large.jpg)
Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm | British Journal of General Practice
![Prostate-specific Antigen Density Cutoff of 0.15 ng/ml/cc to Propose Prostate Biopsies to Patients with Negative Magnetic Resonance Imaging: Efficient Threshold or Legacy of the Past? - European Urology Focus Prostate-specific Antigen Density Cutoff of 0.15 ng/ml/cc to Propose Prostate Biopsies to Patients with Negative Magnetic Resonance Imaging: Efficient Threshold or Legacy of the Past? - European Urology Focus](https://www.eu-focus.europeanurology.com/cms/asset/33b30d11-3bb9-4802-9431-3c5b77d6c9e6/gr1.jpg)
Prostate-specific Antigen Density Cutoff of 0.15 ng/ml/cc to Propose Prostate Biopsies to Patients with Negative Magnetic Resonance Imaging: Efficient Threshold or Legacy of the Past? - European Urology Focus
![Cancer de la prostate : parler pour lutter contre "la paralysie de l'érection" - Institut de Cancérologie de Bourgogne Cancer de la prostate : parler pour lutter contre "la paralysie de l'érection" - Institut de Cancérologie de Bourgogne](https://institut-cancerologie-bourgogne.fr/wp-content/uploads/2022/11/PHOTO-2022-11-22-10-25-09-1.jpg)
Cancer de la prostate : parler pour lutter contre "la paralysie de l'érection" - Institut de Cancérologie de Bourgogne
![Prostate-Specific Antigen Testing: Overview, Physiologic Characteristics of PSA, Other Prostate Cancer Markers Prostate-Specific Antigen Testing: Overview, Physiologic Characteristics of PSA, Other Prostate Cancer Markers](https://img.medscapestatic.com/pi/meds/ckb/07/23507tn.jpg)
Prostate-Specific Antigen Testing: Overview, Physiologic Characteristics of PSA, Other Prostate Cancer Markers
![Prostate-Specific Antigen Testing: Overview, Physiologic Characteristics of PSA, Other Prostate Cancer Markers Prostate-Specific Antigen Testing: Overview, Physiologic Characteristics of PSA, Other Prostate Cancer Markers](https://img.medscapestatic.com/pi/meds/ckb/08/23508tn.jpg)
Prostate-Specific Antigen Testing: Overview, Physiologic Characteristics of PSA, Other Prostate Cancer Markers
![Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter | NEJM Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/2004/nejm_2004.350.issue-22/nejmoa031918/production/images/img_medium/nejmoa031918_t2.jpeg)
Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter | NEJM
![InfoCancer - ARCAGY - GINECO - Localisations - Cancers masculins - Cancer de la prostate - Dépistage & prévention - Le dépistage InfoCancer - ARCAGY - GINECO - Localisations - Cancers masculins - Cancer de la prostate - Dépistage & prévention - Le dépistage](http://www.arcagy.org/infocancer/img/meta-valeur-famille-k-masculins-prostate-hp.jpg)